Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study

scientific article published on June 1985

Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1468-2982.1985.0502079.X
P8608Fatcat IDrelease_r2rylhz6tjh2vovavuslzkmnui
P698PubMed publication ID3893732

P2093author name stringP J Schechter
J R Fozard
G P Tell
V Centonze
C Loisy
S Beorchia
P2860cites workEffects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamineQ36004242
Observations on the algogenic actions of adenosine compounds on the human blister base preparationQ40101529
Migraine: a biochemical headache?Q40311465
The neurobiology of vascular head painQ48641194
Central serotonergic nerves project to the pial vessels of the brain.Q48716042
Treatment of the acute migraine attack--current statusQ49117109
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.Q53911337
Special CommunicationQ56096168
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectheadacheQ86
migraineQ133823
placeboQ269829
P304page(s)79-82
P577publication date1985-06-01
P1433published inCephalalgiaQ5063251
P1476titleEffects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study
P478volume5

Reverse relations

cites work (P2860)
Q377484655-HT3 receptor antagonists and migraine therapy
Q377484605-Hydroxytryptamine and the pathophysiology of migraine
Q39545540Blockade of the flare response to intradermal 5-hydroxytryptamine in man by MDL 72.222, a selective antagonist at neuronal 5-hydroxytryptamine receptors
Q35888605Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites
Q38010671Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Q42114573Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity
Q42850031Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
Q28263827On serotonin and migraine: a clinical and pharmacological review
Q38004465Serotonin and nociception
Q40478013Serotonin receptors: Subtypes, functional responses and therapeutic relevance
Q41331950The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications

Search more.